Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pliant Therapeutics Inc
(NQ:
PLRX
)
13.88
-0.10 (-0.72%)
Streaming Delayed Price
Updated: 11:27 AM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pliant Therapeutics Inc
< Previous
1
2
3
4
Next >
7 Cheap Biotech Stocks to Buy Now
August 03, 2022
These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector.
Via
InvestorPlace
Pliant Therapeutics Secures FDA Fast Track Status For Liver Disease Drug
July 21, 2022
Pliant Therapeutics (NASDAQ: PLRX) received Fast Track designation for its lead asset PLN-74809 from the U.S. Food and Drug Administration (FDA) for the potential treatment of primary sclerosing...
Via
Benzinga
4 Analysts Have This to Say About Pliant Therapeutics
July 20, 2022
Over the past 3 months, 4 analysts have published their opinion on Pliant Therapeutics (NASDAQ:PLRX) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program
July 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
July 12, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
July 20, 2022
Upgrades
Via
Benzinga
Short Volatility Alert: Pliant Therapeutics, Inc.
July 12, 2022
On Monday, shares of Pliant Therapeutics, Inc. (NASDAQ: PLRX) experienced volatile short activity. After the activity, the stock price went up +159.01% to $23.00. The overall sentiment for PLRX has...
Via
Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Are Pliant Therapeutics Shares Rallying Today?
July 11, 2022
Via
Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
July 13, 2022
Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.
Via
Benzinga
What's Going On With Pliant Therapeutics Stock?
July 12, 2022
Pliant Therapeutics Inc (NASDAQ: PLRX) shares are trading lower Tuesday after the company announced a proposed $150 million offering.
Via
Benzinga
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
July 12, 2022
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Via
Benzinga
After-Hours Alert: Why Pliant Therapeutics Stock Is Moving
July 11, 2022
Pliant Therapeutics Inc (NASDAQ: PLRX) shares are volatile in Monday's after-hours session after the company announced a proposed $150 million offering.
Via
Benzinga
Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge
July 11, 2022
U.S. stocks traded lower toward the end of trading as investors digested the recent jobs report for the month of June.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 11, 2022
Via
Benzinga
Stocks Lower Midday as Tech Slumps
July 11, 2022
Stocks are lower midday, with the Dow Jones Industrial Average and Nasdaq Composite both down triple digits, as investors prepare for this week's inflation data and the start of earnings season.
Via
Talk Markets
Pliant Therapeutics Stock Just Doubled And Hit A 10-Month High — Here's Why
July 11, 2022
The company's IPF treatment is proving itself where others didn't.
Via
Investor's Business Daily
Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher
July 11, 2022
U.S. stocks traded lower midway through trading following the release of jobs report on Friday.
Via
Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
July 11, 2022
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.
Via
Benzinga
Why U.S. Stocks Are Trading Lower; AZZ Earnings And More
July 11, 2022
U.S. stocks traded lower this morning as investors digested the recent jobs report for the month of June.
Via
Benzinga
Why Is Pliant Therapeutics (PLRX) Stock Soaring Today?
July 11, 2022
Pliant Therapeutics (PLRX) stock is rocketing higher on Monday after revealing data from a Phase 2 clinical trial of PLN-74809.
Via
InvestorPlace
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
July 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via
Benzinga
Why Is Twitter Down By More Than 5%? 22 Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Gainers Inpixon (NASDAQ: INPX) rose 25.8% to $0.2305 in pre-market trading after gaining more than 22% on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
May 25, 2022
Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of...
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...
Via
Benzinga
Read Why Pliant Therapeutics Shares Are Soaring Today
April 13, 2022
Pliant Therapeutics Inc (NASDAQ: PLRX) says that with just two FDA-approved Idiopathic Pulmonary Fibrosis drugs, it believes that is a high unmet need.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 31, 2022
On Thursday, 92 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.